Evaluation of PD-L1, PD-L2, PD-1 and cytotoxic immune response in oral lichen planus

被引:13
|
作者
Costa, Nadia Lago [1 ]
Goncalves, Julie Ane Maria [1 ]
de Lima, Sara Lia Goncalves [1 ]
de Arruda, Jose Alcides Almeida [2 ]
Miranda, Ana Carolina Campos [1 ]
Mesquita, Ricardo Alves [1 ,2 ]
da Silveira, Ericka Janine Dantas [3 ]
Batista, Aline Carvalho [1 ]
机构
[1] Univ Fed Goias, Sch Dent, Dept Stomatol Oral Med & Oral Pathol, Praca Univ S-N,Setor Univ, BR-74605220 Goiania, Go, Brazil
[2] Univ Fed Minas Gerais, Sch Dent, Dept Oral Surg & Pathol, Belo Horizonte, MG, Brazil
[3] Univ Fed Rio Grande do Norte, Dept Dent, Postgrad Program Odontol Sci, Natal, RN, Brazil
关键词
immunogenicity; immunohistochemical; lichen planus; mouth diseases; programmed cell death-1 ligand-2 protein; T-lymphocyte receptor; MALIGNANT-TRANSFORMATION; T-CELLS; EVASION MECHANISMS; EXPRESSION; MICROENVIRONMENT; PATHWAY; LESIONS; B7-DC;
D O I
10.1111/odi.13344
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective To investigate the expression of programmed death-ligands 1 and 2 (PD-L1, PD-L2), programmed death-1 (PD-1), CD8 and granzyme B (GrB), as well as its correlation with the severity of oral lichen planus (OLP). Materials and Methods In a collaborative study, 33 cases of OLP were evaluated according to the latest criteria proposed by the American Academy of Oral and Maxillofacial Pathology (AAOMP/2016) and were submitted to immunohistochemistry. Positivity was measured semiquantitatively (PD-L1, PD-L2) and quantitatively (PD-1, CD8, GrB). The severity of OLP was assessed according to clinical subtype, symptomatology and response to corticosteroid therapy. Results Most OLPs were considered to be negative for PD-L1 (66.6%), but high expression of PD-L2 (96.9%) by keratinocytes and immunoinflammatory cells was observed. PD-1(+) cell density/mm(2) was reduced compared to CD8(+) cells. A low cytotoxic immune response (CD8:GrB ratio) was also demonstrated. Interestingly, there were fewer GrB(+) cells in the intraepithelial region in reticular OLP compared to erosive/bullous OLP. Conclusions PD-L1/PD-1 pathways appear to be compromised in OLP due to low PD-L1 expression in most samples. In contrast, PD-L2 overexpression associated with a possible regulation of the cytotoxic immune response suggests an immune tolerance that may contribute to the chronic profile of OLP.
引用
收藏
页码:1246 / 1254
页数:9
相关论文
共 50 条
  • [31] AKT/mTOR Signal Cascade and Expression of PD-1, PD-L1, and PD-L2 in Gastric Cancer
    L. V. Spirina
    A. V. Avgustinovich
    S. G. Afanas’ev
    I. V. Kondakova
    M. Yu. Volkov
    A. Yu. Dobrodeev
    A. I. Boronkina
    Bulletin of Experimental Biology and Medicine, 2020, 170 : 75 - 78
  • [32] TARGETING PD1/PD-L1/PD-L2 SIGNALING IN ENDOMETRIOSIS
    Mamillapalli, Ramanaiah
    Golden, Adriana
    Taylor, Hugh S.
    Gawde, Nimisha
    FERTILITY AND STERILITY, 2023, 120 (04) : E307 - E307
  • [33] Characterization of Soluble Immune Checkpoint Protein PD-1, PD-L1 and PD-L2 Levels in Different Types of Lymphoid Malignancies
    Mortensen, Julie Bondgaard
    Yoanna, Vladimirova
    Hansen, Ida Monrad
    Bjerre, Mette
    d'Amore, Francesco
    BLOOD, 2018, 132
  • [34] Currently Used Laboratory Methodologies for Assays Detecting PD-1, PD-L1, PD-L2 and Soluble PD-L1 in Patients with Metastatic Breast Cancer
    Jeong, Seri
    Lee, Nuri
    Park, Min-Jeong
    Jeon, Kibum
    Song, Wonkeun
    CANCERS, 2021, 13 (20)
  • [35] Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues
    Ishida, M
    Iwai, Y
    Tanaka, Y
    Okazaki, T
    Freeman, GJ
    Minato, N
    Honjo, T
    IMMUNOLOGY LETTERS, 2002, 84 (01) : 57 - 62
  • [36] Robust Preanalytical Performance of Soluble PD-1, PD-L1 and PD-L2 Assessed by Sensitive ELISAs in Blood
    Krueger, Kimberly
    Mayer, Zsuzsanna
    Kottmaier, Marc
    Gerckens, Miriam
    Boeck, Stefan
    Luppa, Peter
    Holdenrieder, Stefan
    BIOMEDICINES, 2022, 10 (10)
  • [37] Expression of the Immune Modulators of the PD-1: PD-L1 Axis in oral Leukoplakia
    Ries, Jutta
    Wehrhan, Falk
    Baran, Christoph
    Agaimy, Abbas
    Danzer, Eva
    Bolzel, Stella
    Buettner-Herold, Maike
    Kesting, Marco
    Weber, Manuel
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 99 - 100
  • [38] PD-L1 and PD-L2 expression in colorectal cancer
    Zeynep, Ozgul
    Funda, Canaz
    Evrim, Yilmaz
    Deniz, Arik
    Bulent, Yildiz
    Fatih, Yasar. N.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2023, 66 (01) : 31 - 37
  • [39] PD-L2 generates a signal through the PD-1 co-receptor distinct from that of PD-L1
    Srinivasamani, Anupallavi
    Liu, Qinying
    Curran, Michael
    JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
  • [40] Expression of Immunomodulatory Molecules PD-1, PD-L1, and PD-L2, and their Relationship With Clinicopathologic Characteristics in Endometrial Cancer
    Sungu, Nuran
    Yildirim, Melahat
    Desdicioglu, Raziye
    Aydogdu, Ozge Basaran
    Kilicarslan, Aydan
    Dogan, Hayriye Tatli
    Yazgan, Aylin Kilic
    Akyol, Mesut
    Erdogan, Fazli
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2019, 38 (05) : 404 - 413